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Summary
Leptin activates the long form of the leptin receptor (LRb) to control feeding and neuroendocrine function and thus regu-
late adiposity. While adiposity influences insulin sensitivity, leptin also regulates glucose homeostasis independently of
energy balance. Disruption of the LRb/STAT3 signal in s/s mice results in hyperphagia, neuroendocrine dysfunction, and
obesity similar to LRb null db/db mice. Insulin resistance and glucose intolerance are improved in s/s compared to db/db
animals, however, suggesting that LRb/STAT3-independent signals may contribute to the regulation of glucose homeosta-
sis by leptin. Indeed, caloric restriction normalized glycemic control in s/s animals, but db/db mice of similar weight and
adiposity remained hyperglycemic. These differences in glucose homeostasis were not attributable to differences in insulin
production between s/s and db/db animals but rather to decreased insulin resistance in s/s mice. Thus, in addition to
LRb/STAT3-mediated adiposity signals, non-LRb/STAT3 leptin signals mediate an important adiposity-independent role in
promoting glycemic control.Introduction
The incidence of type 2 diabetes in industrialized nations has
increased dramatically over the past several decades and con-
tinues to increase; much of this increase is attributable to the
burgeoning incidence of obesity in these populations (Green,
1997; Hubert et al., 1983). Leptin, the product of the obese
(ob) gene (Friedman and Halaas, 1998; Zhang et al., 1994), is
a hormone that is secreted by adipose tissue to signal the
status of body energy stores to the central nervous system
(CNS; Halaas et al., 1995). As a signal of energy sufficiency,
adequate leptin levels suppress feeding and regulate neuroen-
docrine function (Friedman and Halaas, 1998; Ahima et al.,
1996, 1997; Heiman et al., 1997; Yu et al., 1997). Disrupted
leptin action in ob/ob (devoid of leptin) and db/db mice (devoid
of the signaling, or LRb, leptin receptor) results in hyperphagia
and obesity, endocrine dysfunction, and predisposition to dia-
betes.
In addition to its role in regulating glucose homeostasis by
controlling energy balance and thus adiposity, numerous lines
of evidence suggest a direct role for CNS leptin action in regu-
lating glucose homeostasis. Not only is the impaired glycemic
control in animals with disruption in leptin or LRb action not
reversed by pair feeding or fasting, but glycemic control is rea-
sonably normal in other similarly obese rodents, such as the Ay
mouse (Kahn and Rossetti, 1998). Furthermore, exogenously
administered leptin acutely enhances glycemic control in ob/ob
mice prior to noticeable effects upon feeding or adiposity, and
leptin administration regulates hepatic glucose flux in wild-type
as well as ob/ob mice (Liu et al., 1998; Burcelin et al., 1999;
Kamohara et al., 1997; Barzilai et al., 1999). Furthermore, both
in human patients and in animal models of lipodystrophic dia-
betes, leptin administration improves insulin sensitivity and dia-CELL METABOLISM : MARCH 2005 · VOL. 1 · COPYRIGHT © 2005 ELSEbetes, while food restriction does not (Petersen et al., 2002;
Oral et al., 2002; Shimomura et al., 1999; Colombo et al., 2002;
Ebihara et al., 2001). These leptin actions on glucose homeo-
stasis appear to be mediated via the CNS, as similar effects
are observed upon intracerebroventricular (ICV) as well as pe-
ripheral administration of leptin in rodents (Liu et al., 1998), and
brain-restricted transgenic expression of LRb predominantly
rescues the obesity/diabetes phenotype of db/db mice (Kowal-
ski et al., 2001; Chua et al., 2004; Cohen et al., 2001). It has
also been suggested that leptin may directly regulate insulin
production by the pancreatic β cell, as incubation of primary
islet cultures with leptin results in a suppression of insulin
secretion (Kulkarni et al., 1997).
Leptin binding to LRb activates the associated Jak2 tyrosine
kinase to initiate downstream signaling (Ihle and Kerr, 1995;
Taniguchi, 1995; Kloek et al., 2002). LRb signaling can be con-
ceived of as originating from three major sites within the acti-
vated receptor complex: from each of two tyrosine phosphory-
lation sites on LRb itself (Tyr985 and Tyr1138) and from signaling
motifs on the LRb-associated Jak2 molecule (Kloek et al.,
2002; Bjorbaek et al., 2001; Banks et al., 2000). While signals
mediated directly by motifs on the LRb-associated Jak2 are
poorly characterized, it is well known that Tyr985 recruits the
binding of the protein tyrosine phosphatase, SHP-2 and the
inhibitory suppressor of cytokine signaling-3 (SOCS3), while
Tyr1138 specifically binds and activates the latent transcription
factor, signal transducer and activator of transcription-3
(STAT3; Banks et al., 2000; Bjorbaek et al., 2000; Li and Fried-
man, 1999; Symes et al., 1997; White et al., 1997; Vaisse et al.,
1996; Bates et al., 2003).
By studying mice in which the gene for the leptin receptor
(lepr) was replaced with a substitution mutant at Tyr1138
(leprs1138) by homologous targeting, we have previously shownVIER INC. DOI 10.1016/j.cmet.2005.02.001 169
A R T I C L Ethat disruption of the LRb/STAT3 signal in homozygous (s/s)
mice, results in hyperphagia, reduced energy expenditure, and
obesity with preserved reproductive and growth function
(Bates et al., 2003; Bates et al., 2004). Here we utilize this
model of single pathway leptin resistance to investigate the
role of the LRb/STAT3 pathway in leptin control of glucose ho-
meostasis. We demonstrate that while LRb/STAT3 signaling is
important for the regulation of glucose homeostasis via feeding
and adiposity, LRb/STAT3-independent signals regulate insulin
sensitivity independently of effects on energy balance.
Results and discussion
Improved glucose homeostasis in s/s compared
to db/db mice
We have previously shown that disruption of the LRb/STAT3
signal in s/s mice results in hyperphagia, decreased metabolic
rate/energy expenditure, and increased adiposity similar to that
observed in db/db mice (Bates et al., 2003, 2004). Compared
to db/db mice that become floridly diabetic, however, the alter-
ations in glucose homeostasis in obese s/s animals are rela-
tively mild (Figure 1A): while the serum insulin concentrations
of ad libitum-fed 8-week-old male s/s and db/db mice were
similarly 10- to 15-fold elevated compared to +/+ animals (p =
NS s/s versus db/db) and the blood glucose concentrations for
s/s animals were elevated to approximately 15 mM, the blood
glucose of db/db animals was increased to an average of >30
mM (p < 0.001 versus s/s). Note also that 4/10 db/db animals
had blood glucose concentrations that read “Hi” on the gluco-
meter, denoting glucose concentrations >35 mM, although we
recorded these as 35 mM when calculating average blood glu-
cose concentrations. Interestingly, while not floridly hypergly-
cemic, db/+ animals displayed increased circulating insulin
(p < 0.05) and tended to have higher glucose levels (trend, p =
0.1) compared to s/+ animals with similarly elevated feeding
and adiposity. Furthermore, ob/ob and s/s littermates on the
segregating C57Bl/6;129 background from compound hetero-
zygote intercrosses yielded similar data as C57Bl/6 db/db and
s/s animals: ob/ob animals were dramatically more hyperglyce-
mic than s/s mice, although ob/ob and s/s animals were simi-
larly hyperinsulinemic (Figure 1B). These data confirm that the
differences observed between s/s mice and mice devoid of all
leptin signals are independent of genetic background.
Similarly, while s/s animals display increased fasting blood
glucose and a trend toward glucose intolerance during intra-
peritoneal glucose tolerance test (IPGTT) compared to +/+ ani-
mals (Figures 1C and 1D), the fasting glucose concentrations
of db/db mice were further elevated, and the area under the
IPGTT curve was increased by 40% for db/db compared to s/s
(p = 0.05) as well as +/+ (p < 0.01) animals. Furthermore, s/s
mice were significantly more sensitive to insulin at short times
in an intraperitoneal insulin tolerance test than were db/db ani-
mals (Figure 1E).
In aggregate, these data suggested that while the disruption
of LRb/STAT3 signaling in s/s animals results in increased adi-
posity and insulin resistance, LRb/STAT3-independent signals
that are intact in s/s but not in db/db animals also contribute
to glycemic control. While it is formally possible that the mod-
est but statistically significant difference in adiposity between
s/s and db/db animals (Bates et al., 2003; and see Figure 3)
could contribute to the observed differences in glycemic con-170trol between these two genotypes, the finding that s/s animals
fail to progress to further elevated blood glucose concentra-
tions when followed to 24 weeks of age (Figure 1F) while con-
tinuing to increase in weight (not shown) suggested to us that
this effect is independent of adiposity.
Similar activation of the HPA axis in s/s and db/db mice
Since db/db (and ob/ob) animals are known to have increased
activity of the hypothalamic-pituitary-adrenal (HPA) axis and
this HPA axis hyperactivity contributes to their insulin resis-
tance (Wittmers and Haller, 1983), we examined HPA axis activ-
ity in s/s and db/db animals to determine whether LRb/STAT3-
independent signals in s/s animals might suppress the HPA
axis and thereby improve glycemic control in s/s compared to
db/db mice. We thus measured serum corticosterone levels
and plasma ACTH levels in +/+, s/s, and db/db mice that were
accustomed to daily handling (Figure 2). Serum corticosterone
levels were similarly elevated by 2.5-fold in s/s and db/db mice
compared to +/+ mice (Figure 2A). In spite of this elevation of
corticosterone levels, plasma ACTH levels were elevated by
10% in the s/s and db/db mice compared to +/+ animals (Fig-
ure 2B). This elevated ACTH in the face of hypercorticostero-
nemia indicates inappropriate central activation of the HPA axis
in s/s and db/db mice. Since both s/s and db/db mice possess
similarly elevated HPA axis activity, these data demonstrate
that LRb/STAT3 signaling is crucial for the regulation of HPA
activity by leptin and further suggest that differences in glucose
homeostasis between s/s and db/db animals are not attribut-
able to differences in glucocorticoid-induced insulin resistance.
Effects of pair feeding on adiposity and glycemic
control in s/s and db/db mice
Since adiposity as well as central leptin action contributes to
the regulation of glucose homeostasis and since s/s mice dis-
play slightly reduced adiposity compared to db/db animals (Bates
et al., 2003), we undertook a pair-feeding regimen for s/s and
db/db mice to explore the relative contributions of feeding/adi-
posity-dependent and -independent alterations to glucose ho-
meostasis in these animals. We thus fed s/s and db/db mice
the average amount of food consumed by age-matched wild-
type mice from the time of weaning. While ad libitum-fed
db/db mice displayed an almost 2-fold increase in food intake
compared to +/+ mice (p < 0.001) and tended to eat slightly
(5%) more than s/s mice (Figure 3A), there was no statistically
significant difference in 24 hr food intake in s/s compared to
db/db mice. Pair feeding of s/s and db/db animals resulted in
a 25%–30% decrease in body weight compared to ad libitum-
fed animals by six weeks of age (p < 0.01 versus ad libitum),
although pair-fed (PF) s/s and db/db animals weighed substan-
tially more than the wild-type animals to which they had been
pair fed (p < 0.01), consistent with their increased metabolic
efficiency (Figure 3B; Bates et al., 2004). While not different in
body weight through six weeks of age, PF s/s animals weighed
slightly more than PF db/db animals by 8 weeks of age (p <
0.05), consistent with the improved insulin-mediated energy
storage in s/s animals (see discussion below).
While serum leptin levels for s/s and db/db mice trended
down following pair feeding, the reduction in leptin levels was
not statistically significant compared to ad libitum-fed animals,
suggesting that the secretion of leptin by adipose tissue may
be near maximal at the levels of adiposity achieved by theseCELL METABOLISM : MARCH 2005
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rupted leptin receptor signaling
A) Blood glucose and serum insulin in ad libitum-fed
8-week-old male C57Bl/6 animals of the following
genotypes +/+, s/+, s/s, db/+, and db/db mice.
Mean blood glucose and serum insulin levels are
plotted ±SEM; n = 8–11 per genotype.
B) Glucose and insulin in ad libitum-fed C57;129 ani-
mals. Blood glucose and serum insulin levels were
measured in 8-week-old ad libitum-fed male control
(?/+), s/s, and ob/ob mice on the same C57;129
mixed genetic background and mean values ±SEM
are plotted; n = 8 per genotype.
C) Glucose tolerance. Male +/+, s/+, s/s, db/+, and
db/db mice were fasted overnight and the GTT per-
formed at 9:30 a.m. Following an initial blood glu-
cose reading, a bolus of sterile glucose was ad-
ministered at time zero and blood glucose
measurements taken at timed intervals. Average
glucose reading at each time is plotted for each ge-
notype ±SEM; n = 8–20 per genotype.
D) Area under the GTT curve was calculated for
each animal in (C) and averages for each genotype
are plotted ± SEM.
E) Insulin tolerance test. Male s/s and db/db mice
were fasted overnight and the ITT performed at 9:30
a.m. Following an initial blood glucose reading, a
bolus of insulin was administered at time zero and
blood glucose measurements taken at timed in-
tervals. Average glucose reading at each time is
plotted for each genotype ±SEM; n = 8 per ge-
notype.
F) Effect of age on glycemic control. Ad libitum-fed
male +/+, s/+, s/s, db/+, and db/db mice were moni-
tored longitudinally from 8–24 weeks of age for
blood glucose and serum insulin. Average values for
each genotype at each age are plotted ±SEM. n =
6–13 per genotype, except for db/db mice, which
began to die at age 9 weeks; numbers of surviving
db/db animals are indicated in parentheses above
the error bars for these weeks. All panels: +/+ (filled
circles), s/s (filled squares), s/+ (empty squares),
db/db or ob/ob (filled triangles), and db/+ (empty
triangles). Bars with different letters are statistically
different (p < 0.01).total fat mass) and lean body mass that was similar or reducedpared to ad libitum-fed db/db animals and equalized the per-
Figure 2. HPA axis activity in mice with disrupted
LRb signaling
Ad libitum-fed female mice of the indicated geno-
types that were accustomed to daily handling were
sacrificed for the collection of trunk blood on the
morning that they were 8 weeks of age. Serum or
plasma was collected and corticosterone (A) and
ACTH (B) were measured. Average values for each
genotype are plotted ±SEM. Bars with different let-
ters are different by Student’s unpaired t test (p <
0.01); n = 8–11 per genotype.animals (Figure 3C). Analysis by DEXA of body composition of
8-week-old animals demonstrated that while pair feeding
db/db animals to +/+ levels decreased percent body fat com-CELL METABOLISM : MARCH 2005cent adiposity of the PF s/s and db/db animals, the PF animals
still displayed percent adiposity levels more than twice those
of wild-type animals (Figure 3D; approximately 3-fold elevated171
A R T I C L EFigure 3. Feeding, adiposity, and glycemic control
in PF s/s and db/db mice
A) Food intake in +/+ animals for pair-feeding
studies was determined by weighing of pellet chow
every 24 hr; 24 hr food intake of ad libitum-fed s/s
and db/db mice was determined at 4, 6, and 8
weeks of age for comparison. Body weight (B) and
serum leptin levels (C) were determined weekly for
animals of each genotype and feeding condition.
Body lipid content was determined by DEXA for
8-week-old animals of each genotype and feeding
condition, and mean values are plotted in (D). All
panels: values represent mean ±SEM; n = 7–8 per
genotype and condition. Genotypes as indicated in
(D); for all other panels: +/+ (filled circles), s/s (filled
squares), PF s/s (empty squares), db/db (filled trian-
gles), and PF db/db (empty triangles). Bars with dif-
ferent letters are statistically different (p < 0.01).compared to wild-type animals (data not shown). Thus, these
data are consistent with the increased metabolic efficiency of
s/s and db/db animals (Bates et al., 2004), resulting in in-
creased fat storage compared to wild-type animals with equiv-
alent caloric intake.
Caloric restriction delayed by 1–2 weeks but did not prevent
the onset of hyperglycemia in db/db animals, while it suc-
ceeded in normalizing blood glucose levels in PF s/s animals
with similar levels of body fat as the PF db/db mice (Figure 4A),
suggesting that the differences in glycemic control observed
between s/s and db/db animals were independent of differ-
ences in feeding and adiposity. Longitudinal analysis of serum
insulin levels in these animals demonstrated the reduction of
circulating insulin levels in PF s/s and PF db/db animals by
caloric restriction (Figure 4B), consistent with a reduction of
insulin resistance due to decreased adiposity. These data also
demonstrated dramatically increased insulin resistance in PF
db/db compared to PF s/s animals from the time of weaning,
as gauged by the maintenance of glycemic control in the PF s/s
animals at insulin levels lower than the levels that failed to main-
tain glycemic control in the db/db animals. Indeed, in the 8-week-
old PF animals, lower levels of circulating insulin in PF s/s than
PF db/db animals resulted in normoglycemia for PF s/s ani-
mals, while the higher levels of insulin in PF db/db mice failed
to control blood glucose levels in the normal range. These data
suggest increased insulin resistance in db/db animals com-
pared to s/s animals independent of any differences in food
intake or adiposity. While the preceding data clearly demon-
strate increased insulin resistance in db/db than s/s animals,
the reduction of serum insulin levels in PF db/db compared to
ad libitum-fed db/db mice at 8 weeks of age in the face of the
continued hyperglycemia of PF db/db animals could indicate
an additional defect in insulin production in db/db animals.172Islet function in s/s and db/db mice
In order to formally address whether a decrease in insulin pro-
duction contributes to the lower insulin levels and poor gly-
cemic control in the PF db/db mice, we assessed circulating
insulin C-peptide levels in these mice at 8 weeks of age (Figure
4C). Insulin C-peptide levels were increased and highly variable
in ad libitum-fed s/s and db/db animals compared to controls,
consistent with the high variable levels of insulin secretion that
likely result from the increased amount and frequency of feed-
ing in these animals. In contrast, the morning C-peptide levels
in the PF s/s mice, while elevated approximately 2-fold com-
pared to +/+ animals, were less variable, consistent with the
consumption of most of their calories at the onset of the dark
cycle and the subsequent absence of recent feeding. PF db/db
mice displayed insulin C-peptide levels twice as high as those of
s/s animals, suggesting that the decrease in circulating insulin
in PF db/db mice compared to s/s mice does not reflect de-
creased insulin production in the db/db animals but increased
clearance and that insulin production is actually 2-fold higher
in PF db/db than in PF s/s mice.
In order to more carefully examine the insulin-producing is-
lets in these mouse models, we examined their size and mor-
phology in histologic sections of pancreata from 8-week-old
animals (Figure 5). Assessment of islet area and morphology
revealed a 50%–80% increase in islet area in both s/s and
db/db mice compared to +/+ mice, which is consistent with
the increased demands for insulin production resulting from the
insulin resistance of these animals. While the differences in islet
area between ad libitum-fed s/s and db/db mice were not sig-
nificant (trend, p = 0.1), the islet area of PF s/s animals was
significantly smaller than of db/db mice under all feeding con-
ditions (p < 0.05), consistent with a greater demand placedCELL METABOLISM : MARCH 2005
LRb/STAT3 signaling and glycemic control 2Figure 4. Glycemic control in mice with leptin re-
ceptor mutations
Morning blood glucose (A) and serum insulin (B)
concentrations were determined weekly for animals
of all genotypes and feeding conditions. Serum in-
sulin C-peptide concentrations were determined in
8-week-old animals from all genotypes and feeding
conditions (C). All values represent mean ±SEM for
n = 7–8 animals for each genotype and condition.
Genotypes as indicated in (C); for all other panels:
+/+ (filled circles), s/s (filled squares), PF s/s (empty
squares), db/db (filled triangles), and PF db/db
(empty triangles). Bars with different letters are sta-
tistically different (p < 0.01).upon the islets of ad libitum-fed and PF db/db mice due to
increased insulin resistance.
Hepatic steatosis and gene expression in s/s
and db/db mice
In aggregate, these data suggest that there are significant dif-
ferences in glucose homeostasis in s/s compared to db/db mice
that cannot be attributed to differences in adiposity or insulin
production between these two models. Others have suggested
that central leptin action regulates hepatic function and insulin
sensitivity (Liu et al., 1998; Kahn and Rossetti, 1998; Rossetti
et al., 1997; Asilmaz et al., 2004), and we hypothesized that
some of these actions of leptin might be mediated by LRb/
STAT3-independent signals. We therefore examined hepatic
steatosis and the hepatic mRNA expression of a number of
genes that have been reported by others to be regulated by
leptin treatment (Figure 6). As expected, total liver weight and
triglyceride content was increased in ad libitum-fed s/s and
db/db mice, in agreement with the known hepatic steatosis in
db/db mice (Figures 6A and 6B). Pair feeding normalized the
weight of s/s and db/db mice and reduced the liver triglyceride
content to near normal, suggesting that a significant portion of
the hepatic steatosis of these models could be accounted for
by excessive caloric intake and that differences in liver triglyc-
eride content could not account for differences in glycemic
control between the PF s/s and PF db/db mice.
To further assess hepatic function, we measured mRNA ex-
pression for several key regulators of hepatic metabolic func-
tion using semiquantitative RT-PCR (Figures 6C–6F). We ob-
served that IRS-2 mRNA was decreased to near or below the
range of detection in both s/s and db/db mice compared to
wild-type animals but that IRS-2 mRNA expression was nor-CELL METABOLISM : MARCH 2005malized or enhanced by pair feeding in each of these models
(Figure 6C), suggesting that recent feeding and/or insulin ac-
tion regulates the expression of IRS-2 mRNA, as opposed to a
primary effect of leptin (i.e., independent of feeding; Shimo-
mura et al., 1999). Although liver PEPCK mRNA expression of
ad libitum-fed db/db mice trended slightly up, it was not signifi-
cantly different from wild-type mice, nor was PEPCK mRNA
expression altered in the liver of PF s/s animals (Figure 6D).
The PEPCK mRNA expression in PF db/db animals was signifi-
cantly elevated (p < 0.01) compared to wild-type animals, how-
ever. In contrast, the ad libitum-fed s/s animals displayed sup-
pressed PEPCK mRNA levels compared to other groups.
Notably, PEPCK mRNA expression was appropriately de-
creased in ad libitum-fed s/s animals that feed during the light
as well as the dark cycle. This appropriate suppression of
PEPCK mRNA in the ad libitum-fed s/s animals is consistent
with increased hepatic insulin sensitivity in these animals com-
pared to db/db animals as opposed to an effect of leptin, per
se, since levels increased during the food restriction associ-
ated with pair feeding.
Steroyl CoA desaturase-1 (SCD-1) is a leptin-suppressed
target gene in the liver that may contribute to overall body en-
ergy homeostasis by regulating energy expenditure (Cohen et
al., 2002). SCD-1 mRNA expression was elevated compared to
+/+ mice in db/db and s/s animals independently of feeding
status, consistent with the regulation of this gene by leptin in
a manner independent of nutritional status and independently
of LRb/STAT3 signaling (Figure 6E). Thus, while this gene is
regulated by leptin action independently of body adiposity, it is
not responsible for the differences in insulin sensitivity between
s/s and db/db mice, consistent with the recent findings of oth-
ers (Asilmaz et al., 2004).173
A R T I C L EFigure 5. Islet size and morphology
Pancreas morphology was assessed by evaluating at least three sections (7 microns thick) cut 150 microns apart from each pancreas from 8-week-old male mice.
Sections were immunostained with a cocktail of antibodies against non-β cell hormones (glucagon, somatostatin, and pancreatic polypeptide) as described earlier
(Kulkarni et al., 1999). β cell area was evaluated using Openlab image analysis software for calibrating the magnification for each micrograph (Image Pro Plus; Media
Cybernetics, Silver Spring, Maryland). Images of sections were captured using a BX60 microscope (Olympus) equipped with a U-PMTVC video adaptor and an HV-
C20 TV camera (Hitachi, Tokyo). The percentage of cells positive for β or non-β cells was calculated and corrected for pancreatic weight. Panel: All values represent
mean ±SEM for n = 5 animals for each genotype and condition. Genotypes as indicated. Bars with different letters are statistically different (p < 0.01).The sterol regulatory binding protein SREBP1c isoform is
predominantly found in liver and adipose tissue and mediates
several transcriptional actions of insulin (Brown and Goldstein,
1997; Yahagi et al., 2002). As in ob/ob mice, we found that
hepatic SREBP1 mRNA expression was significantly increased
in db/db and s/s mice compared to wild-type; however, s/s
mice had lower expression levels compared to db/db mice
(Figure 6F). Pair feeding did not alter expression levels of
SREBP1 mRNA despite reducing serum insulin levels in these
mice. These data suggest insulin-independent control of
SREBP1 mRNA expression and are consistent with the im-
proved insulin sensitivity of s/s mice compared to db/db mice.
LRb/STAT3 signaling in the regulation
of glucose homeostasis
Others have shown that leptin regulates insulin sensitivity by
two methods: one dependent upon adiposity/feeding, and the
other via a CNS-mediated pathway independent of adiposity174and feeding (Petersen et al., 2002; Oral et al., 2002; Shimomura
et al., 1999; Colombo et al., 2002; Ebihara et al., 2001; Liu et
al., 1998; Burcelin et al., 1999; Kamohara et al., 1997; Barzilai
et al., 1999). Our present results are consistent with this model
and further suggest that LRb/STAT3 signaling is critical for the
feeding/adiposity-dependent regulation of glucose homeosta-
sis, in line with the requirement for this signal in the regulation
of feeding and energy expenditure (Bates et al. 2003, 2004):
glucose homeostasis in freely feeding obese s/s mice, though
improved compared to db/db mice, is impaired.
Although insulin resistance is not entirely ameliorated in the
PF s/s animals (as evidenced by their increased circulating in-
sulin and insulin C-peptide levels), this is consistent with the
increase in circulating glucocorticoids in the s/s animals and
with the increased adiposity of the PF s/s animals due to de-
creased energy expenditure of these animals compared to
wild-type mice (Bates et al., 2004). PF s/s mice display similar
percent adiposity as PF db/db animals; at 8 weeks of age theCELL METABOLISM : MARCH 2005
LRb/STAT3 signaling and glycemic control 2Figure 6. Liver composition and gene expression
Livers from ad libitum and PF animals were removed
following sacrifice of 8-week-old animals and
weighed (A). Similar portions of each liver were then
dissected and frozen for the determination of tri-
glyceride content (B) or for the isolation of RNA for
the examination of gene expression (C–F). Expres-
sion of mRNA for IRS-2 (C), PEPCK (D), SCD-1 (E),
and SREBP1c (F) was determined by semiquantita-
tive RT-PCR using the resulting liver RNA. All data
are shown as mean ±SEM; n = 7–8 per genotype
and condition. mRNA expression is reported in arbi-
trary units (A.U.) for comparison within each panel.
Genotypes as indicated. Bars with different letters
are statistically different (p < 0.01).PF s/s body mass and thus total adipose tissue mass is also
higher than for PF db/db mice. The divergence of weight be-
tween PF s/s and PF db/db mice after 6 weeks of age may
reflect caloric loss by the PF db/db mice due to glycosuria.
The normoglycemia of PF s/s but not PF db/db mice (with iden-
tical total and hepatic adiposity) thus suggests that LRb/
STAT3-independent signals constitute the majority of the feed-
ing/adiposity-independent regulation of glucose homeostasis
by leptin. The appropriate suppression of hepatic PEPCK mRNA
expression in s/s mice is similarly consistent with this conclu-
sion. The differences in glycemic control between s/s and db/
db animals cannot be attributed to decreased insulin pro-
duction in db/db animals since islet area and insulin production
(reflected in insulin C-peptide levels) are actually higher in the
db/db cohort than in s/s animals. While it is theoretically pos-
sible that some of the observed differences between PF s/s
and PF db/db animals could reflect secondary effects of hyper-
glycemia in the PF db/db mice, it is clear that important differ-
ences between these two lines must exist to explain the gene-
sis of the hyperglycemia in the PF db/db mice; many or all of
the differences we have observed could reasonably reflect
these primary alterations in insulin action and glycemic control.CELL METABOLISM : MARCH 2005It is not clear whether the feeding/adiposity-independent
regulation of glycemic control by leptin represents an increase
in insulin sensitivity per se or whether leptin acts to regulate
hepatic glucose output independently of any effect on insulin
signaling. It is clear from the work of others that this leptin
effect is mediated via the CNS, as central manipulation of LRb
expression or administration of leptin mediates similar effects
(Cohen et al., 2001; Liu et al., 1998; Kowalski et al., 2001; Chua
et al., 2004). Furthermore, recent work has suggested that the
central effects of leptin on hepatic glucose production are me-
diated independently of the hypothalamic melanocortin system
(Gutierrez-Juarez et al., 2004). Consistently, we demonstrated
impaired hypothalamic proopiomelanocortin expression with
relatively preserved repression of hypothalamic NPY expres-
sion in s/s mice (Bates et al., 2003). Since leptin also regulated
the development and plasticity of the metabolic circuitry of the
brain (Pinto et al., 2004; Bouret et al., 2004), it is also possible
that alterations in either of these parameters between s/s and
db/db mice may contribute to differences in glycemic control.
While it is theoretically possible that Tyr1138 of LRb may me-
diate signaling by an unknown STAT3-independent LRb signal-175
A R T I C L Eing pathway that would also be disrupted in s/s animals, there
are no data to suggest that this is the case. Thus, in aggregate,
these results suggest that while the LRb/STAT3 signaling path-
way is required for the action of the hypothalamic melanocortin
system and thereby the regulation of feeding, energy expen-
diture, and adiposity, LRb/STAT3-independent leptin signals
(perhaps via the hypothalamic NPY system) primarily mediate
the central and adiposity-independent effects of leptin on gly-
cemic control. Since other growth factors and cytokines acti-
vate STAT3 in the brain, presumably contributing to the more
severe phenotype of neuronal STAT3 knockout mice than that
of s/s mice (Gao et al., 2004), the untested possibility exists
that these LRb-independent STAT3 signals may also contribute
to glycemic control.
As we grapple with the increasing incidence of the metabolic
syndrome and type 2 diabetes in developed nations, it is cru-
cial to understand the mechanisms contributing to the devel-
opment of obesity and diabetes and to define the similarities
and differences in the processes controlling obesity and diabe-
tes. While defects in the β cell are likely to contribute to the
onset of diabetes, our data demonstrate no differences in islet
function between animals devoid of LRb/STAT3 signaling and
animals lacking LRb entirely. It is clear, however, that abroga-
tion of the LRb/STAT3 signal contributes to the development
of hyperglycemia secondary to hyperphagia and obesity but
also that the LRb/STAT3 pathway does not contribute to the
adiposity-independent control of glucose homeostasis. Rather,
LRb/STAT3-independent leptin pathways contribute to the di-
rect, feeding/adiposity-independent regulation of glycemic
control; understanding these pathways will likely be important
for defining the mechanisms contribute to the development of
type 2 diabetes.
Experimental procedures
Experimental animals
All animal experimentation was conducted in accordance with mandated
standards of humane care, approved by the Institutional Animal Care and
Use Committee. Mice were housed in individually ventilated cages on a 12
hr light-dark cycle with ad libitum access to LabDiet autoclavable laboratory
mouse chow 5021, a high-calorie breeder chow, and water, unless other-
wise indicated. C57BL/6 (six generations backcrossed) mice heterozygous
for the leprs1138 mutation (s/+) were bred to generate s/s and wild-type
littermates for study. C57BL/6 db/+ animals obtained from the Jackson
Laboratory (Bar Harbor, Maine) were intercrossed to generate db/db and
db/+ animals for study. C57Bl/6 ob/+ animals were obtained from Jackson
laboratories and intercrossed with s/+ animals on the segregating C57Bl/
6;129 genetic background to generate N1F1 s/+, ob/+ compound heterozy-
gotes that were subsequently intercrossed to generate N1F2 s/s and ob/ob
littermate animals for study.
Glucose tolerance test
Mice were fasted overnight for 16 hr. At 9:30 a.m. an initial blood glucose
reading was taken (Glucometer Elite) and mice were administered an intra-
peritoneal bolus of glucose (2 g/kg body weight). Whole venous blood was
obtained from the tail vein to measure blood glucose 15, 30, 60, and 120
min after glucose administration.
Insulin tolerance test
Mice were fasted overnight for 16 hr. At 9:30 a.m. an initial blood glucose
reading was taken (Glucometer Elite) and mice were administered an intra-
peritoneal bolus of insulin (4 units/kg body weight). Whole venous blood
was obtained from the tail vein to measure blood glucose 15, 30, and 60
min after insulin administration.176Pair-feeding studies
All mice were weaned at 21 days of age and housed individually. Twenty-
four hour food intake was monitored by weighing chow daily for male wild-
type mice for 5 weeks (until 8 weeks of age). Each day s/s and db/db mice
were provided the average amount of food consumed by age-matched
wild-type mice. Body weight was assessed at 3, 4, 6, and 8 weeks of age
and blood samples were obtained by tail-vein nick for the measurement of
blood glucose, serum leptin, and serum insulin.
Body composition
8-week-old male ad libitum-fed mice were briefly anaesthetized with Avertin
(tribromoethanol:tert-amyl alcohol, 0.015 ml/g, i.p.) and subject to dual en-
ergy X-ray absorptiometry (DEXA; Lunar PIXImus2 densitometer, GE Medi-
cal Systems, Madison, Wisconsin) for the analysis of fat and lean body
mass.
Hormone measurement
For the measurement of serum insulin and leptin, blood was obtained by
tail vein nick and serum was collected and stored at −20°C. Serum insulin
and leptin concentrations were measured by ELISA (Crystal Chem, Illinois).
For the measurement of parameters of the H-P-A axis, all mice were han-
dled daily for at least 10 days prior to the day of the experiment. Mice
were sacrificed at 10 a.m. by cervical dislocation and decapitated for the
collection of trunk blood. For the measurement of corticosterone, serum
was collected, stored at −20°C, and serum concentrations were assessed
by RIA (ICN). For the measurement of ACTH, trunk blood was collected in
microtainer spin tubes containing EDTA (Becton Dickinson, Franklin Lakes,
New Jersey) and centrifuged. Plasma was collected and stored at −80°C and
ACTH assessed by RIA (ICN). Insulin C-peptide was measured by RIA (Linco,
St. Louis, Missouri) of serum obtained from terminal bleeds of 8-week-old
male mice.
Liver analysis
Wet liver weight was measured on freshly dissected livers of 8-week-old
male mice. The left lobe of the liver was snap frozen for later determination
of triglyceride content and for the purification of RNA for gene expression
analysis. Triglyceride content was assessed using the L-Type TG H
N-(2-hydroxy-3-sulfopropyl)-3,5-dimetoxyaniline (HDAOS) biochemical as-
say using 50 mg frozen tissue (Wako Diagnostics, Richmond, Virginia).
Briefly, tissue was homogenized in 5 ml of 150 mM sodium chloride, 0.1%
Triton X-100, and 10 mM Tris (pH 8.0) and incubated at 60°C for 1 hr. Tri-
glycerides were measured in 30 l homogenate at a wavelength of 600 nm.
Lipid standards of known concentration were used to generate a standard
curve.
Liver gene expression
Total RNA was extracted from 50–100 mg liver samples using the Ultraspec
RNA Isolation System (Biotecx Inc., Houston, Texas) as described pre-
viously and DNase-treated using RQ1 RNase-free DNase (Promega, Madi-
son, Wisconsin). For determination of relative RNA concentration, total liver
RNA was subjected to automated fluorescent RT-PCR on an ABI 7700 (Ap-
plied Biosystems, Foster City, California) or MJ research Opticon (Waltham,
Massachusetts). Primers used were: ctggagtattatgagtcgagaagaagtgg (for-
ward IRS-2), tgtagagggcgatcaggtacttgt (reverse IRS-2), TET-tcaacaagcgcg
cggacgc-TAMRA (probe IRS-2); tcccaggaagatgaagggtttat (forward Adipo-
nectin Receptor 2). PEPCK was determined using a predesigned taqman
primer/probe mix (Assays-on-Demand mM00440636_m1, Applied Biosys-
tems). Primer/probe mix for SCD-1 and SREBP1 were obtained by submit-
ting 300 bp sequence to Applied Biosystems Assays-by-Design service.
Ribosomal RNA control primers and probes were as supplied by Applied
Biosystems. Each predicted RT-PCR product spanned an intron/exon junc-
tion except for IRS-2, which is essentially intronless; RT-free controls were
run for determinations of all mRNA species studied. Each RT-PCR reaction
was determined to be in the linear range for quantitation by comparison to
serial dilutions of input liver RNA.
Islet morphology
The pancreas was dissected from 8-week-old male mice and immediately
immersed in Bouin’s solution overnight. Rinsed tissue was then fixed inCELL METABOLISM : MARCH 2005
LRb/STAT3 signaling and glycemic control 210% buffered formalin until sectioning (7 microns thick cut 150 microns
apart). Sections were immunostained with a cocktail of antibodies against
non-β cell hormones (glucagon, somatostatin, and pancreatic polypeptide)
as described earlier (Kulkarni et al., 1999). β cell area was evaluated for
three sections from each pancreas using Openlab image analysis software
for calibrating the magnification for each micrograph (Image Pro Plus; Me-
dia Cybernetics, Silver Spring, Maryland). Images of sections were captured
using a BX60 microscope (Olympus) equipped with a U-PMTVC video
adaptor and an HV-C20 TV camera (Hitachi, Tokyo). The percentage of cells
positive for β or non-β cells was calculated and corrected for pancreatic
weight.
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